These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 8977275)
1. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter. Simon MM; Gern L; Hauser P; Zhong W; Nielsen PJ; Kramer MD; Brenner C; Wallich R Eur J Immunol; 1996 Dec; 26(12):2831-40. PubMed ID: 8977275 [TBL] [Abstract][Full Text] [Related]
2. Plasmid DNA and protein vaccination of mice to the outer surface protein A of Borrelia burgdorferi leads to induction of T helper cells with specificity for a major epitope and augmentation of protective IgG antibodies in vivo. Zhong W; Wiesmüller KH; Kramer MD; Wallich R; Simon MM Eur J Immunol; 1996 Nov; 26(11):2749-57. PubMed ID: 8921965 [TBL] [Abstract][Full Text] [Related]
3. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection. Zhong W; Gern L; Kramer M; Wallich R; Simon MM Eur J Immunol; 1997 Nov; 27(11):2942-7. PubMed ID: 9394822 [TBL] [Abstract][Full Text] [Related]
4. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease. Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567 [TBL] [Abstract][Full Text] [Related]
5. Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA. Ding W; Huang X; Yang X; Dunn JJ; Luft BJ; Koide S; Lawson CL J Mol Biol; 2000 Oct; 302(5):1153-64. PubMed ID: 11183781 [TBL] [Abstract][Full Text] [Related]
6. Borrelia burgdorferi outer surface protein (osp) B expression independent of ospA. Liang FT; Caimano MJ; Radolf JD; Fikrig E Microb Pathog; 2004 Jul; 37(1):35-40. PubMed ID: 15194158 [TBL] [Abstract][Full Text] [Related]
7. A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula. Nassal M; Skamel C; Kratz PA; Wallich R; Stehle T; Simon MM Eur J Immunol; 2005 Feb; 35(2):655-65. PubMed ID: 15668917 [TBL] [Abstract][Full Text] [Related]
8. Borrelia burgdorferi strain 25015: characterization of outer surface protein A and vaccination against infection. Fikrig E; Barthold SW; Persing DH; Sun X; Kantor FS; Flavell RA J Immunol; 1992 Apr; 148(7):2256-60. PubMed ID: 1545130 [TBL] [Abstract][Full Text] [Related]
9. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi. Luke CJ; Carner K; Liang X; Barbour AG J Infect Dis; 1997 Jan; 175(1):91-7. PubMed ID: 8985201 [TBL] [Abstract][Full Text] [Related]
10. An ospA frame shift, identified from DNA in Lyme arthritis synovial fluid, results in an outer surface protein A that does not bind protective antibodies. Fikrig E; Liu B; Fu LL; Das S; Smallwood JI; Flavell RA; Persing DH; Schoen RT; Barthold SW; Malawista SE J Immunol; 1995 Dec; 155(12):5700-4. PubMed ID: 7499856 [TBL] [Abstract][Full Text] [Related]
11. Identification of a Borrelia burgdorferi OspA T cell epitope that promotes anti-OspA IgG in mice. Bockenstedt LK; Fikrig E; Barthold SW; Flavell RA; Kantor FS J Immunol; 1996 Dec; 157(12):5496-502. PubMed ID: 8955199 [TBL] [Abstract][Full Text] [Related]
13. Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B. Fikrig E; Tao H; Chen M; Barthold SW; Flavell RA J Clin Invest; 1995 Oct; 96(4):1706-14. PubMed ID: 7560061 [TBL] [Abstract][Full Text] [Related]
14. Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. Pal U; de Silva AM; Montgomery RR; Fish D; Anguita J; Anderson JF; Lobet Y; Fikrig E J Clin Invest; 2000 Aug; 106(4):561-9. PubMed ID: 10953031 [TBL] [Abstract][Full Text] [Related]
15. Protective immunity elicited by rBCG vaccines. Stover CK; Bansal GP; Langerman S; Hanson MS Dev Biol Stand; 1994; 82():163-70. PubMed ID: 7958471 [TBL] [Abstract][Full Text] [Related]
16. The outer surface lipoprotein OspA of Borrelia burgdorferi provides co-stimulatory signals to normal human peripheral CD4+ and CD8+ T lymphocytes. Knigge H; Simon MM; Meuer SC; Kramer MD; Wallich R Eur J Immunol; 1996 Oct; 26(10):2299-303. PubMed ID: 8898937 [TBL] [Abstract][Full Text] [Related]
17. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC. Zhong W; Gern L; Stehle T; Museteanu C; Kramer M; Wallich R; Simon MM Eur J Immunol; 1999 Mar; 29(3):946-57. PubMed ID: 10092099 [TBL] [Abstract][Full Text] [Related]
18. A new approach to a Lyme disease vaccine. Livey I; O'Rourke M; Traweger A; Savidis-Dacho H; Crowe BA; Barrett PN; Yang X; Dunn JJ; Luft BJ Clin Infect Dis; 2011 Feb; 52 Suppl 3():s266-70. PubMed ID: 21217174 [TBL] [Abstract][Full Text] [Related]
19. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype. Schaible UE; Wallich R; Kramer MD; Gern L; Anderson JF; Museteanu C; Simon MM Vaccine; 1993; 11(10):1049-54. PubMed ID: 8212826 [TBL] [Abstract][Full Text] [Related]
20. Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A. Shang ES; Champion CI; Wu XY; Skare JT; Blanco DR; Miller JN; Lovett MA Infect Immun; 2000 Jul; 68(7):4189-99. PubMed ID: 10858236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]